Icosavax, Inc. Annual Operating Income (Loss) in USD from 2020 to 2022

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Icosavax, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2020 to 2022.
  • Icosavax, Inc. Operating Income (Loss) for the quarter ending September 30, 2023 was -$25.3M, a 9.21% decline year-over-year.
  • Icosavax, Inc. Operating Income (Loss) for the twelve months ending September 30, 2023 was -$106M, a 20.1% decline year-over-year.
  • Icosavax, Inc. annual Operating Income (Loss) for 2022 was -$95.1M, a 44.3% decline from 2021.
  • Icosavax, Inc. annual Operating Income (Loss) for 2021 was -$65.9M, a 252% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2022 -$95.1M -$29.2M -44.3% Jan 1, 2022 Dec 31, 2022 10-K 2023-03-30
2021 -$65.9M -$47.2M -252% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-30
2020 -$18.7M Jan 1, 2020 Dec 31, 2020 10-K 2022-03-30
* An asterisk sign (*) next to the value indicates that the value is likely invalid.